Dr. Svetlana Morozkina was graduated from Saint-Petersburg State University (Russia) in 1997 – Department of organic chemistry, Chemistry Faculty. She defended her PhD degree at the same Department and, then she got the Post-Doc position from the Government of Russia for young talent people (Saint-Petersburg State University, 1997-2001). In 2004 she organized the research group under the guidance of Professor Alexander Shavva (he was the head of the Department of Natural Compounds Chemistry for 25 years: 1988-2014) and started her research in the field of the total synthesis, investigation of structure and biological properties of synthetic steroid estrogen analogues. She has/had collaboration with Imperial College of London, German Cancer Research Centre, Charite Klinikum, Erlangen University), University of Lausanne, Biomedicum Centre of Helsinki University, Seoul National University. She also had collaboration with Merck Company (USA) and Bayer Schering Pharma Company (Germany). She was head of the Laboratory at Commercial Firm “Alkorbio” (Saint-Petersburg). She was invited speaker on International Conferences and Congresses. She also was/is: member of organizing Committees of International Conferences; expert of European commission ERA.Net RUS Pilot Joint Call in Innovation projects; consulting person of several Industrial companies; the invited Lecturer in the University of Jyvaskyla; Reviewer of Synthesis and Organic Letters journals; member of the jury of the Intel Baltic Science and Engineering Fair (Regional part of Intel-ISEF), section chemistry. Dr. Morozkina also participated in International grants as researcher and as the head of the Projects. She is author of 48 articles, reviews, Russian and International patents (total 15 patents). She was supervisor of 12 diploma’ works and two PhD students. Start from October 2015 she continues her research at Far Eastern Federal University as the head of the Medicinal Chemistry Laboratory, School of Bio medicine.
Biochemistry, medicinal chemistry, drug discovery, total synthesis, molecular docking, molecular structure, drug targets, endocrine diseases, structure – biological activity relationship.